Related Experiment Video

Updated: May 13, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Tumor suppressor p16(INK4a) inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction

Mee-Hyun Lee1, Bu Young Choi, Yong-Yeon Cho

  • 1The Hormel Institute, University of Minnesota, MN 55912, USA.

Journal of Cell Science
|February 28, 2013
PubMed

Insights

The tumor suppressor p16 inhibits cancer cell growth by interacting with eukaryotic elongation factor 1A2 (eEF1A2). This interaction downregulates eEF1A2 expression and protein synthesis, revealing a novel anti-proliferative mechanism.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Cycle Regulation

Background:

  • p16(INK4a) is a tumor suppressor inhibiting cell cycle progression.
  • The precise mechanisms of p16(INK4a)'s anti-proliferative effects remain unclear.
  • eukaryotic elongation factor (eEF)1A2 is implicated as an oncogene in various cancers.

Purpose of the Study:

  • To elucidate the novel mechanisms underlying the anti-proliferative effects of p16(INK4a).
  • To identify new interacting partners of p16(INK4a).
  • To investigate the functional consequence of the p16(INK4a)-eEF1A2 interaction in cancer cells.

Main Methods:

  • Yeast two-hybrid screening to identify p16(INK4a) interacting partners.
  • Ectopic expression of p16(INK4a) in cancer cells.
  • Luciferase reporter assays to assess protein synthesis inhibition.
  • Microinjection into Xenopus embryos to study translational control.

Main Results:

  • Identified eukaryotic elongation factor (eEF)1A2 as a novel binding partner of p16(INK4a).
  • p16(INK4a) expression reduced eEF1A2 levels and inhibited cancer cell proliferation.
  • p16(INK4a) suppressed protein synthesis, an effect enhanced by co-inhibition of eEF1A2.

Conclusions:

  • p16(INK4a) interacts with eEF1A2, leading to its downregulation.
  • This interaction and subsequent reduction in eEF1A2 function represent a novel mechanism for p16(INK4a)'s tumor-suppressive activity.
  • Targeting the p16(INK4a)-eEF1A2 pathway may offer new therapeutic strategies for cancer.
Keywords:
Anti-proliferative effectsOvarian cancerTranslational activityeEF1A2p16INK4a

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...